International Clinical Trial: Development of a Multimodal Prediction Model Based on PSMA-PET/MRI Radiomics for Pathological Characteristics of Prostate Cancer

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131315) titled 'Development of a Multimodal Prediction Model Based on PSMA-PET/MRI Radiomics for Pathological Characteristics of Prostate Cancer' on Sept. 1.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Prostatic acinar adenocarcinoma and its postoperative pathological features, including extracapsular extension and seminal vesicle invasion.

Intervention: EPE-negative group:N/A SVI-positive group:N/A EPE-positive group:N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-03

Tar...